We found that PANTR1 expression was significantly related to several clinical parameters of glioma prognosis, including WHO grade (p < 0.001), IDH status (p < 0.001), primary therapy outcome (p=0.02), gender (p=0.023), histological type (p < 0.001), and EGFR status (p < 0.001) (t-test for each group). Here, PANTR1 is linked to glioma.